GLP‑1 doctors and weight loss clinics in Longmont, CO
65 clinicians in Longmont prescribed a GLP-1 to Medicare patients in 2024, over half of them internists and family doctors; none lists obesity medicine as a specialty. You can contact one of them, or skip the search and start online with a program that serves Colorado.
Data from CMS, NPPES and the US Census, read November 18, 2026.
Longmont at a glance
- Clinicians in Longmont wrote 57.7 Medicare GLP-1 claims per 1,000 residents in 2024: above the average of Colorado’s largest cities (40.1) and below the 500 largest US cities (70.0).
- Ozempic was the most prescribed, with 38% of those claims; semaglutide (Ozempic, Wegovy, Rybelsus) made up 40% and tirzepatide (Mounjaro, Zepbound) 33%.
- Of the 65 clinicians listed here, 41 are internists, family doctors or general practitioners and 3 are endocrinologists; 34 offer telehealth visits to Medicare patients, by CMS’s clinician file.
- 1 clinics, medical spas and practices in Longmont have a website that mentions semaglutide, tirzepatide or another GLP-1.
- No clinician practicing in Longmont lists obesity medicine as a specialty. The nearest city with one is Boulder, CO, 13 miles away.
The top 3 online programs that serve Colorado
Ranked by the glp1.health Score, which weighs safety and price transparency most, among the 31 programs we rate that serve Colorado. We leave out any program with an open FDA warning letter. How we score · All rankings
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Where to get a GLP‑1 in person in Longmont
Practices in Longmont with GLP‑1 prescribers
Medicare group practices with a location in Longmont, by their clinicians’ GLP-1 prescriptions in 2024. The patient rating is CMS’s survey score (0 to 100) where CMS publishes one.
Obesity medicine doctors and endocrinologists in Longmont
Clinicians practicing in Longmont who list obesity medicine or endocrinology in the national provider registry. A listed specialty is what the clinician reported; it is not proof of board certification.
Weight loss clinics and medical spas in Longmont
From open map data (Overture Maps), with what each place’s own website mentions where we read it. A mention is not a check that a place prescribes GLP-1s: ask who the prescribing clinician is and check their license.
GLP‑1 prescribers in Longmont by ZIP code
Where the clinicians on this page practice, by the ZIP code of their practice address.
Hospitals where Longmont’s GLP‑1 prescribers practice
The hospitals CMS lists for these clinicians, with the hospital’s own CMS ratings. A hospital’s stars rate the hospital, not the clinicians who work there.
Compounding pharmacies in Longmont
Pharmacies in Longmont registered as compounding pharmacies in the national provider registry, with the state license numbers they report. Being on this list says nothing about GLP-1s. A compounding pharmacy is licensed and inspected by the state board of pharmacy; Colorado has 4 outsourcing facilities (503B) on the FDA register, which the FDA also inspects.
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) in Longmont
What clinicians in Longmont prescribed to Medicare patients in 2024, by brand. Ozempic, Wegovy and Rybelsus are semaglutide; Mounjaro and Zepbound are tirzepatide.
Paying yourself? Compare compounded semaglutide programs, compounded tirzepatide programs and the programs for Zepbound, Wegovy and Ozempic.
In person in Longmont or online: how they compare
Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound.
Does Health First Colorado cover GLP‑1s for weight loss?
Health First Colorado does not cover medications prescribed for weight loss: Appendix P lists weight-loss drugs, including Saxenda, as not a covered benefit, and the preferred drug list says prior authorization for GLP-1s prescribed solely for weight loss will not be approved. Wegovy (pen or tablet) can be approved with prior authorization only to lower cardiovascular risk in adults with heart disease and overweight or obesity, or for MASH, and Zepbound only for moderate to severe obstructive sleep apnea with obesity. Foundayo does not appear on the preferred drug list.
Checked November 10, 2026 against the state’s own documents. GLP-1 coverage in Colorado: Medicaid, the state employee plan and Medicare, with sources
GLP‑1 doctors in Longmont: questions
Nearby cities
- Boulder, CO13 mi
- Broomfield, CO15 mi
- Loveland, CO17 mi
- Thornton, CO19 mi
- Westminster, CO20 mi
- Arvada, CO23 mi
Other cities in Colorado
- 1.Ahrefs Keywords Explorer, US, Matching terms, intent = Local, volume >= 40Ahrefsretrieved 2026-11-18
- 2.2025 Gazetteer Files: PlacesUS Census Bureauretrieved 2026-11-18
- 3.Census Geocoder, batch address locations (Public_AR_Current)US Census Bureauretrieved 2026-11-18
- 4.City and Town Population Totals, Vintage 2025 (SUB-EST2025)US Census Bureauretrieved 2026-11-18
- 5.Cartographic Boundary File, Places, 2025, 1:500,000 (cb_2025_us_place_500k)US Census Bureauretrieved 2026-11-18
- 6.2020 ZCTA to Place Relationship FileUS Census Bureauretrieved 2026-11-18
- 7.Clinic websites (homepage + one GLP-1 page)each clinicretrieved 2026-11-18
- 8.Facility Affiliation Data (27ea-46a8)CMS Provider Data Catalogretrieved 2026-11-18
- 9.PY 2024 Clinician Public Reporting: MIPS Measures and Attestations (7d6a-e7a6)CMS Provider Data Catalogretrieved 2026-11-18
- 10.Doctors and Clinicians National Downloadable File (mj5m-pzi6), modified 2026-10-30CMS Provider Data Catalogretrieved 2026-11-18
- 11.PY 2024 Group Public Reporting: Patient Experience (8c70-d353)CMS Provider Data Catalogretrieved 2026-11-18
- 12.PY 2024 Group Public Reporting: MIPS Measures and Attestations (0ba7-2cb0)CMS Provider Data Catalogretrieved 2026-11-18
- 13.Patient survey (HCAHPS) - Hospital (dgck-syfz)CMS Provider Data Catalogretrieved 2026-11-18
- 14.Hospital General Information (xubh-q36u)CMS Provider Data Catalogretrieved 2026-11-18
- 15.PY 2024 Clinician Public Reporting: Overall MIPS Performance (a174-a962)CMS Provider Data Catalogretrieved 2026-11-18
- 16.Medicare Part D Prescribers - by Provider and Drug, data year 2024CMSretrieved 2026-11-18
- 17.Registered Outsourcing Facilities (503B)US FDAretrieved 2026-11-18
- 18.NPPES Data Dissemination, November 2026 (V2)CMSretrieved 2026-11-18
- 19.NUCC Health Care Provider Taxonomy code set v26.1National Uniform Claim Committeeretrieved 2026-11-18
- 20.Open Payments General Payment Data, program year 2025 (published 2026-06-30)CMSretrieved 2026-11-18
- 21.Overture Maps Places, release 2026-10-21.0Overture Maps Foundationretrieved 2026-11-18
- 22.Wikidata (matched on GNIS ID, P590) and Wikimedia CommonsWikimediaretrieved 2026-11-18
Data read November 18, 2026. Clinicians, practices and pharmacies come from public CMS and NPPES files; clinics and medical spas from open map data (Overture Maps). We do not verify that a clinician or clinic offers GLP-1 treatment or takes new patients: call first. This page is educational and is not medical advice. How we built this directory